Table 3 Comparison of adverse events of patients after ERCP
Type of Papillary, n (%) | |||||
|---|---|---|---|---|---|
Type 1 (n = 115) | Type 2 (n = 29) | Type 3 (n = 52) | Type 4 (n = 21) | P value | |
Adverse events, n (%) | 8 | 3 | 4 | 3 | 0.69 |
PEP | 6 | 3 | 3 | 2 | 0.71 |
Bleeding | 1 | 0 | 1 | 0 | 0.79 |
Perforation | 0 | 0 | 0 | 0 | - |
Cholangitis | 1 | 0 | 1 | 1 | 0.48 |